Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Comment by mercedesmanon May 14, 2023 8:23am
123 Views
Post# 35447256

RE:RE:RE:RE:RE:RE:Ok let’s say they get to 90…

RE:RE:RE:RE:RE:RE:Ok let’s say they get to 90…

Most charts will tell you ( eg SH/quote) that the yearly high was .62 in July/Aug 2022
if you meant closing price you should have said so... but I guess it didn't make your erronious point that the price has only been down since Seto was hired. 

Like I said,  Seto could have done, and still can do, much better with :
- a better US listing & presence
- more and better IR and analyst coverage
- less FUD ruckers running amuck 
-earlier focus on the Tigris enrolment dilemma
- a more active and engaged BOD 

All IMHO of course. 


MM 

 

<< Previous
Bullboard Posts
Next >>